| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology and Critical Care Medicine, Gifu University School of Medicine, Gifu City, Gifu 500-8705, Japan
Address correspondence to Shuji Dohi, MD, PhD, Department of Anesthesiology and Critical Care Medicine, Gifu University School of Medicine, Tsukasamachi-40, Gifu city, Gifu 500-8705, Japan. Address e-mail to shu-dohi@cc.gifu-u.ac.jp.
To clarify the supraspinal and spinal actions of a cholinergic agonist, carbachol, and an opioid, oxycodone, we studied their antinociceptive and behavioral effects when administered into brainstem medial pontine reticular formation (mPRF) or spinal subarachnoid space with or without pretreatment of muscarinic receptor subtype antagonist. Sprague-Dawley rats were implanted with a 24-gauge stainless steel guide cannula into the mPRF and chronically implanted with a lumbar intrathecal catheter. Antinociception was tested using tail flick latency, motor coordination was evaluated by the rotarod test, and overt sedation was assessed using a behavioral checklist. Carbachol (0.54.0 µg) administered into the mPRF produced significant dose- and time-dependent antinociception, sedation, and motor dysfunction. These were completely blocked by pretreatment with atropine and the M2 muscarinic antagonist, methoctramine, and partially blocked by pretreatment with M1 pirenzepine but not with M3 p-fHHSiD. Oxycodone administered into the mPRF did not produce such effects. Spinal carbachol and oxycodone produced antinociception without any behavioral effects; their antinociceptive effects were completely blocked by pretreatment with atropine and M2 antagonist. These results suggest that the antinociceptive action of carbachol is mediated by muscarinic cholinergic receptor activation, especially by M2 receptor subtype in mPRF and spinal cord, and that although oxycodone seems unlikely to affect the cholinergic transmission of mPRF, spinal oxycodone-induced analgesia is at least partly mediated via the activation of M2 receptor subtype at the spinal cord.
Implications: Carbachol-induced antinociception and sedation is mediated with the activation of M2 muscarinic receptors. Oxycodone administered into brainstem medial pontine reticular formation did not cause any antinociceptive or behavioral effects, but its spinal administration produced a significant antinociception via M2 muscarinic receptor activation
This article has been cited by other articles:
![]() |
H.-M. Zhang, D.-P. Li, S.-R. Chen, and H.-L. Pan M2, M3, and M4 Receptor Subtypes Contribute to Muscarinic Potentiation of GABAergic Inputs to Spinal Dorsal Horn Neurons J. Pharmacol. Exp. Ther., May 1, 2005; 313(2): 697 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Yanagidate and S. Dohi Epidural oxycodone or morphine following gynaecological surgery Br. J. Anaesth., September 1, 2004; 93(3): 362 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Duttaroy, J. Gomeza, J.-W. Gan, N. Siddiqui, A. S. Basile, W. D. Harman, P. L. Smith, C. C. Felder, A. I. Levey, and J. Wess Evaluation of Muscarinic Agonist-Induced Analgesia in Muscarinic Acetylcholine Receptor Knockout Mice Mol. Pharmacol., November 1, 2002; 62(5): 1084 - 1093. [Abstract] [Full Text] [PDF] |
||||
|